Page last updated: 2024-09-05

glycyl-proline-1-naphthylamide and metformin

glycyl-proline-1-naphthylamide has been researched along with metformin in 1 studies

*Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289) [MeSH]

*Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289) [MeSH]

Compound Research Comparison

Studies
(glycyl-proline-1-naphthylamide)
Trials
(glycyl-proline-1-naphthylamide)
Recent Studies (post-2010)
(glycyl-proline-1-naphthylamide)
Studies
(metformin)
Trials
(metformin)
Recent Studies (post-2010) (metformin)
60017,7933,17612,526

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Demuth, HU; Hinke, SA; Hoffmann, T; Kühn-Wache, K; McIntosh, CH; Pederson, RA1

Other Studies

1 other study(ies) available for glycyl-proline-1-naphthylamide and metformin

ArticleYear
Metformin effects on dipeptidylpeptidase IV degradation of glucagon-like peptide-1.
    Biochemical and biophysical research communications, 2002, Mar-15, Volume: 291, Issue:5

    Topics: Animals; Dipeptides; Dipeptidyl Peptidase 4; Glucagon; Glucagon-Like Peptide 1; Humans; Hydrolysis; Hypoglycemic Agents; Kinetics; Metformin; Peptide Fragments; Protein Precursors; Recombinant Proteins; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Substrate Specificity; Swine

2002